| Term 
 
        | Acetylsalicylic acid (Aspirin) |  | Definition 
 
        | acetylation of COX (1&2) enzymes, irreversible inhibition; inhibits platelet aggregation;
 tx inflammation, fever, pain, HA, arthritis, dysmenorrhea, RA (large dose);
 SE - GI ulcer, tinnitus, hearing loss, hepatic injufy, Reyes', asthma, inc bleeding time;
 CI with bleeding disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - inhibitor of COX-1,2,(3); analgesic and antipyretic;
 NOT useful for anti-inflammatory;
 SE - HEPATOTOXICITY;
 No effects on platelets, NO GI IRRITATION
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - POTENT; anti-inflammatory, analgesic, antipyretic;
 tx gout, arthritis;
 Used to close Ductus Arteriosus;
 SE - GI IRRITATION, CNS effects (HA, dizziness, depression), renal dysfxn;
 CI in pregnancy
 |  | 
        |  | 
        
        | Term 
 
        | Ibuprofen (Advil, Motrin) |  | Definition 
 
        | NSAID - reversible COX inhibitor; Alter platelet (prolonged bleeding), anti-inflamm, antipyretic, analgesic;
 tx RA (3200mg), pain (400mg/6hrs);
 SE- GI irritation (less than others);
 CI in pregnancies
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - reversible COX inhibitor; Alter platelet (prolonged bleeding), anti-inflamm, antipyretic, analgesic;
 Long half-life - 14hrs, so 2xday dosing;
 SE- GI irritation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - reversible COX inhibitor; Alter platelet (prolonged bleeding), anti-inflamm, antipyretic, analgesic;
 LONG HALF-LIFE - 40hrs, once a day;
 SE- GI irritation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - heteroaryl acetic acid deriv; POTENT analgesic, moderate anti-inflamm;
 IM, oral, parenteral admin;
 SHORT-TERM USE ONLY;
 tx post-op pain and inflamm, topical for eye inflamm (alergies or post-op);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - heteroaryl acetic acid deriv; potent COX inhibition;
 tx RA, OA;
 SE - GI, elevation of hepatic aminotransferase activities;
 CI for pregnancy
 |  | 
        |  | 
        
        | Term 
 
        | Anthrotec (trade name) Diclofenac + Misoprostol
 |  | Definition 
 
        | NSAID + PGE1 agonist - heteroaryl acetic acid deriv; gastric protection
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGE1 analog; gastric protection
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - Enolic Acid; Anti-inflamm, antipyretic, analgesic;
 Equiv w/ asprin, indo, naproxen;
 LONG HALF-LIFE - 50hrs, one a day;
 SE - GI, RENAL (high risk);
 Drug interaction - lithium (reduce clearance)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - Enolic Acid; More selective for COX2;
 LONG HALF-LIFE - one a day;
 tx OA, RA;
 SE - GI (better than others)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID - selective COX2; anti-inflamm, antipyretic, analgesic;
 tx OA, RA, acute pain, dysmenorrhea;
 SE - CV, some GI uleration, dyspepsia, inhibits labor, renal alteration, hypersensitivity rxns;
 Drug interaction- "heart meds", diuretics, coumadin
 |  | 
        |  | 
        
        | Term 
 
        | Methotrexate (*Rheumatrex*) |  | Definition 
 
        | DMARD - inhibits DHFR to inhibit purine biosynth; tx RA!, leukemias, psoriasis, immunosuppressor (dec Igs, TNF, IL-1,6);
 SE - hepatotoxicity, infections, teratogenic;
 CI - poor renal fxn, NSAIDs dec clearance, pregnancy (Cat X!)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD - inhibits pyrimidine synth; tx mild RA;
 SE - skin rash, hepatic toxicity (BLACK BOX!), long-term teratogen (1-2 yrs to clear, use cholestyramidine to conjugate), myelosuppression (bone marrow);
 |  | 
        |  | 
        
        | Term 
 
        | Sulfasalazine (Azulfidine) |  | Definition 
 
        | DMARD - prodrug; met. to sulfapyridine (unknown benefit) and 5ASA (therapeutic);
 tx RA, UC, Crohn's;
 SE - GI, DEC. WBCs
 |  | 
        |  | 
        
        | Term 
 
        | Hydroxychloroquine (Plaquenil) |  | Definition 
 
        | DMARD - anti-malaria; 2nd line for mild RA;
 long onset (3-4 mo.) but well tolerated;
 SE - nausea, gastric pain, HEMOLYSIS, retinal damage (visual symptoms!)
 |  | 
        |  | 
        
        | Term 
 
        | Gold (Myochrysine) (Aurolate) |  | Definition 
 
        | DMARD - unknown mech; tx. primarily for RA, once was 1st-line choice;
 IM admin;
 SE - skin, mucous membranes (mouth 15%), renal, blood dyscrasias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD - TNF inhibitor; Reduce circulating TNF-a and block action at receptor;
 mech - fusion of 75 TNF receptor to human IgG;
 produced in CHO cells (hamster);
 admin SC injection 2x a week (3-4 day half life);
 tx RA who don't respond to other DMARDs, psoriatic arth, AS, plaque psorisis;
 SE - injection site rxn, infection, auto-Ab
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD - TNF inhibitor; Reduce circulating TNF-a and block action at receptor;
 chimeric IgG1 monoclonal Ab, induces lysis of activated TNF-alpha expressing cells;
 IV admin 0 and 2 weeks, every other month;
 tx RA, Crohn's, psoriatic arth, AS, UC, plaque psoriasis;
 SE - injection site rxn, infection, auto-Ab
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD - TNF inhibitor; Reduce circulating TNF-a and block action at receptor;
 Human monoclonal anti-TNF-alpha Ab;
 SC injection, every other week;
 tx RA, AS, Crohn's, psoriatic arthritis, plaque psoriasis;
 SE - injection site rxn, infection, auto-Ab
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD - TNF inhibitor; Reduce circulating TNF-a and block action at receptor;
 Human monoclonal Ab;
 tx RA and other arthritis;
 SC admin, once per month
 |  | 
        |  | 
        
        | Term 
 
        | Cimzia (Certolizumab Pegol) |  | Definition 
 
        | DMARD - TNF inhibitor; Reduce circulating TNF-a and block action at receptor;
 Anti-TNF Ab conjugated to polyethylene glycol;
 SC injection, once a month;
 tx arthritis, Crohn's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD; IL-1 receptor antagonist;
 Competitively binding to IL-1 type I receptor;
 tx - mod to severe RA, tried other DMARDs;
 Use after failed TNF-inhibitor therapy;
 SC injection;
 SE - injection site rxns;
 CI - w/ other TNF blocking agents
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD; T-cell costim blocker;
 CTLA4 conjugated w/ IgG, binds CD28 on Tcell, blocks response and cytokines (TNF);
 admin IV first 0,2,4 weeks then once a month;
 Use after failed TNF-inhibitor therapy;
 SE - inc infections (immunocompromised)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD; depletion of B cells;
 monoclonal Ab against CD20 on Bcells, dec cytokine production;
 tx RA who failed to respond to other TNF antagonists
 |  | 
        |  | 
        
        | Term 
 
        | Salicylate drug interactions (3) |  | Definition 
 
        | Oral hypoglycemic, phenytoin, uricosurics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR Agonist; active but conv to M-6-glucaronide (100x potency);
 tx mod/severe pain;
 4 hr half life - accumulation;
 extensive (70%) first pass metabolism;
 Use in pts taking MAO-Is;
 SE - tolerance, constipation, renal clearance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); oral and parenteral admin;
 tx mod/SEVERE pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); long acting;
 tx mod/severe pain;
 high abuse potential
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); tx mod/severe pain;
 50% inactivated, first pass;
 less spasmogenic, no miosis, less constipation;
 Toxic met. (normeperidine) can accumulate to produce seizure risk;
 CI - lethal w/ MAO-inhibitors, CHILDREN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); po admin;
 tx abuse withdrawl/cravings, dampen peaks/troughs of drug conc during weaning
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); tx mod/severe pain;
 80x potency;
 transdermal patch for chronic;
 rapid onset, short duration - anesthesia IV;
 Use in pts taking MAO-Is;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); tx mod/severe pain;
 rapid onset, short duration - anesthesia IV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); tx mild pain;
 dec efficacy;
 renal clearance;
 norproproxyphene (metabolite) produces cardiac toxicity;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); Low affinity, 10% conv to morphine;
 oral or parenteral admin;
 renal clearance, resistance in 10% caucasians;
 tx mild pain, cough suppressant (@brainstem)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOR agonist (morphine-like); long duration (8-12 hrs);
 tx severe pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | po admin; very long half life;
 PRODRUG - conv to 2 active metabolites;
 tx abuse withdrawl/cravings, dampen peaks/troughs of drug conc during weaning
 |  | 
        |  | 
        
        | Term 
 
        | Buprenorphine (Buprenex)(Subutex) |  | Definition 
 
        | MOR partial agonist (low action), KOR antagonist; dec abuse potential;
 po admin;
 tx addiction/abuse;
 SE - abstinence syndrome (if morph-dependent)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid mixed agonist/antagonist; bind and inactivates MOR;
 activates KOR;
 tx mod/severe pain, but analgesic effect is sl. dec;
 no constipation, no respiratory depression;
 SE - abstinence syndrome;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid mixed agonist/antagonist; bind and inactivates MOR;
 activates KOR;
 tx mod/severe pain, but analgesic effect is sl. dec;
 no constipation, no respiratory depression;
 SE - abstinence syndrome;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid receptor antagonist; LONG DURATION (24 hrs);
 po admin, extensive first pass;
 tx alcohol abuse (craving and relapse)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid receptor antagonist; long duration (4hr);
 tx opioid OD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid receptor antagonist; IV only: rapid onset, short duration (esp compared to morhphine), dose accordingly;
 EXTENSIVE P.O. FIRST PASS METABOLISM;
 tx opioid OD, reverses respiratory depression;
 can cause opioid withdrawal; start low, go slow
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antitussive - cough suppression; opiate derivative;
 no analgesia;
 acts on non-opioid receptors;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opiate derivative; dec GI motility, peristalsis and secretion = inc absorption;
 tx diarrhea;
 no CNS effects - doesn't cross BBB
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | analgesia; dec respiration;
 dec GI activity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | analesia; GI regulation;
 autonomics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | dec respiration (RR and TV); dec cough;
 pupillary constriction/ miosis at high doses (NO TOLERANCE);
 nausea and vomiting;
 euphoria (bolus IV);
 sedation;
 seizures (high doses)
 |  | 
        |  | 
        
        | Term 
 
        | Peripheral actions of opoids (5) |  | Definition 
 
        | Constipation (dec motility and secretions)- NO TOLERANCE; Vasodilation;
 Urticaria;
 Contraction of bladder and sphincter;
 Dec uterine contraction
 |  | 
        |  | 
        
        | Term 
 
        | Major drug interactions of Opiates (4) |  | Definition 
 
        | Sedatives/hypnotics; Sympathomimetics;
 Antihistamines;
 MAO inhibitor antidepressants
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit ascending pain paths; activate decending pain-suppression paths
 |  | 
        |  | 
        
        | Term 
 
        | Diphenhydramine (Benadryl) |  | Definition 
 
        | 1st Gen antihistamine - ether deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 
        | Dimenhydrinate (Dramamine) |  | Definition 
 
        | 1st Gen antihistamine - ether deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen antihistamine - ether deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 
        | Chlorpheniramine (Chlor-Trimenton) |  | Definition 
 
        | 1st Gen antihistamine - Alkylamine deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 
        | Brompheniramine (Dimentane) |  | Definition 
 
        | 1st Gen antihistamine - Alkylamine deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen antihistamine - Phenothiazine deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen antihistamine - Piperazine deriv; Long lasting (4-24hrs);
 Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen antihistamine - Piperazine deriv; Long lasting (4-24hrs);
 Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen antihistamine - Piperazine deriv; Long lasting (4-24hrs);
 Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen antihistamine - Alkylamine deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen antihistamine - piperidine deriv; Longer duration, non-sedating, no anticholinergic fxn, SAFE for asthmatics;
 tx allergy, hayfever, rhintis, urticaria, insect bites, contact flora;
 SE - mild congnitive disturance, some appetite stimulation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen antihistamine - Alkylamine deriv.; Longer duration, non-sedating, no anticholinergic fxn, SAFE for asthmatics;
 tx allergy, hayfever, rhintis, urticaria, insect bites, contact flora;
 SE - mild congnitive disturance, some appetite stimulation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen antihistamine - piperazine deriv; appetite stimulation, some sedation;
 Longer duration, non-sedating, no anticholinergic fxn, SAFE for asthmatics;
 tx allergy, hayfever, rhintis, urticaria, insect bites, contact flora;
 SE - mild congnitive disturance, some appetite stimulation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; high specificity for H1, some muscarinic activity;
 LONG HALF LIFE (27hrs);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; INHIBITS RELEASE of histamine from mast cells;
 more specific for H1;
 tx ocular rhinitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; inhibits histamine, LTs, PAF activity;
 LONG HALF LIFE;
 tx rhinitis and hay fever;
 can use in asthmatics;
 SE - somnolence, taste, nasal burning, ST, dry mouth, TERATOGENIC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; MOST SPECIFIC FOR H1;
 tx ocular rhinitis;
 SE - generally none! (even at high dose)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; antagonizes PAF and LTD4 bronchoconstriction;
 tx allergic rhinitis (+ocular symtpm), urticaria;
 non-sedative;
 approved in EUROPE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; anti-allergic, comp to 2nd gen;
 inhibits histamine and LTC4 release (leukocytes);
 tx asthma, ALLERGIC CONJUNCTIVITIS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd Gen antihistamine; hybrid of 1ST GEN AND 2ND GEN;
 anti-LT and anti-bradykinin;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; B1, [B2], a1, a2;
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; B1, [B2], (some a);
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; B1, [B2];
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; [B2] specific - FAST - reliever or rescue admin;
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; [B2] specific - FAST - reliever or rescue admin;
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; [B2] specific - FAST - reliever or rescue admin;
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; [B2]specific - SLOW - prevention (esp night-time, exercise use);
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonist - Bronchodilator; [B2]specific - SLOW - prevention (esp night-time, exercise use);
 Stim AC to inc cAMP - bronch dilation;
 tx asthma, COPD;
 inhibit release of mediators from mast cells, inhib vasculature perm, promote mucociliary transport;
 SE skeletal m. tremor, nausea, vomit, HA, dec BP, inc HR, arrhythmias, PAO2????? (on discussion board)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinergic antagonist - Bronchodilator; Competitive M blockade;
 dec airway SM constriction, dec mucous secretion;
 SE - pupillary dilation & cycloplegia (X ciliary m)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinergic antagonist - Bronchodilator; Competitive M blockade;
 short acting and no systemic functions;
 dec airway SM constriction, dec mucous secretion;
 SE - pupillary dilation & cycloplegia (X ciliary m)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinergic antagonist - Bronchodilator; Competitive M blockade;
 dec airway SM constriction, dec mucous secretion;
 SE - pupillary dilation & cycloplegia (X ciliary m)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Methylxanthine - Bronchodilator; Inhibit PDE - inc cAMP - bronchodilation;
 Block adenosine recept - bronchodilation;
 Dec release of mediators - anti-inflamm;
 tx asthma/COPD;
 chronotropic, ionotropic, inc CNS act, gastric acid sec, inc SK muscle str (diaphragm);
 SE - (10-20ug/mL)- nausea, vomit, HA, nervous, insomnia, (>20ug/mL)- hypoK, hyperglycemia, tachycardia, arrhy, NM irritability, seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Methylxanthine - Bronchodilator; Inhibit PDE - inc cAMP - bronchodilation;
 Block adenosine recept - bronchodilation;
 Dec release of mediators - anti-inflamm;
 tx asthma/COPD;
 chronotropic, ionotropic, inc CNS act, gastric acid sec, inc SK muscle str (diaphragm);
 SE - (10-20ug/mL)- nausea, vomit, HA, nervous, insomnia, (>20ug/mL)- hypoK, hyperglycemia, tachycardia, arrhy, NM irritability, seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflamm; Alt Cl- channel: mast cells (dec degran), eosinophils (dec inflamm), airway nn (inhibit cough), dec bronchial hyperactivity;
 tx asthma,COPD;
 SE - TASTE, irritation of trachea (cough/bronchospasm)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a Cromolyn - Anti-inflamm; Alt Cl- channel: mast cells (dec degran), eosinophils (dec inflamm), airway nn (inhibit cough), dec bronchial hyperactivity;
 tx asthma,COPD;
 SE - TASTE, irritation of trachea (cough/bronchospasm)
 |  | 
        |  | 
        
        | Term 
 
        | Beclomethasone (Beclovent) |  | Definition 
 
        | Inhaled Glucocorticoid - Anti-inflamm; Dec production of inflamm cytokines;
 Inc prod of anti-inflamm proteins;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - candidiasis, hoarse, dry mouth, dec bone density, dec growth rate (kids), CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhaled Glucocorticoid - Anti-inflamm; Dec production of inflamm cytokines;
 Inc prod of anti-inflamm proteins;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - candidiasis, hoarse, dry mouth, dec bone density, dec growth rate (kids), CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhaled Glucocorticoid - Anti-inflamm; Dec production of inflamm cytokines;
 Inc prod of anti-inflamm proteins;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - candidiasis, hoarse, dry mouth, dec bone density, dec growth rate (kids), CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhaled Glucocorticoid - Anti-inflamm; Dec production of inflamm cytokines;
 Inc prod of anti-inflamm proteins;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - candidiasis, hoarse, dry mouth, dec bone density, dec growth rate (kids), CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhaled Glucocorticoid - Anti-inflamm; Dec production of inflamm cytokines;
 Inc prod of anti-inflamm proteins;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - candidiasis, hoarse, dry mouth, dec bone density, dec growth rate (kids), CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral Glucocorticoid - Anti-inflamm; Dec production of inflamm proteins;
 Inc prod of anti-inflamm cytokines;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - glu intolerance, inc BP and weight, dec bone density, dec growth rate (kids), cataracts, immunosuppression, CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral Glucocorticoid - Anti-inflamm; Dec production of inflamm proteins;
 Inc prod of anti-inflamm cytokines;
 Dec mucus secretion, dec bronch hyperactivity;
 tx asthma, COPD;
 SE - glu intolerance, inc BP and weight, dec bone density, dec growth rate (kids), cataracts, immunosuppression, CUSHINGOID SYNDROME
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Leukotriene receptor blocker - Anti-inflamm; Block LTD4 - dec bronch reactivity/constriction, dec mucosal secretion, dec airway inflamm;
 tx asthma (aspirin-induced);
 SE - GI, URI, nausea, otitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Leukotriene receptor blocker - Anti-inflamm; Block LTD4 - dec bronch reactivity/constriction, dec mucosal secretion, dec airway inflamm;
 tx asthma (aspirin-induced);
 SE - GI, HA, inc liver enzymes, CANCER RISK
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Leukitriene Synth inhibitor - Anti-inflamm; inhibits 5-lipoxygenase and LT formation (B,C,D,E -4);
 dec SM contraction, dec blood vessel perm (leukocyte migration);
 SE - inc hepatic enzymes (watch liver func tests), inhibits CYP1A2 (theophylline)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-IgE - Humanized antibody; Dec severity and freq of asthma attacks;
 tx severe allergic asthma (step 5/6 treatment, slide 32);
 SE - anaphylaxis, cold symptoms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Polyclonal Ab; (use rabbit more) - immunosup; anti-thmocyte globulin;
 Nonspecific binding to T-cells, lose 80-90%;
 tx for bone marrow or organ transplant, aplastic anemia;
 Neutralizing Abs dev = tolerance;
 SE - fever, chills, hypoT, thrombocytopenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Polyclonal Ab - immunosup; anti-thmocyte globulin;
 Nonspecific binding to T-cells, lose 80-90%;
 tx for bone marrow or organ transplant, aplastic anemia;
 Neutralizing Abs dev = tolerance;
 SE - fever, chills, hypoT, thrombocytopenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV immunoglobulin - Immune boost; tx immunodeficiency;
 SE- renal failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mouse anti-CD3 Ab - Immunosup; Tcells in peripheral blood, reversible;
 Neutralizing Abs can dev = TOLERANCE;
 SE - acute hypersensitivity, systemic cytokine-med symp;
 pretreat with high-dose steroids
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Co-stimulation blocker - Immunosup; Fusion protein - blocks CD28 - dec Tcell prolif and apoptosis;
 tx RA;
 SE - HA, dizziness, HTN, GI, infections
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Co-stimulation blocker - Immunosup; Fusion protein - blocks CD28 - dec Tcell prolif and apoptosis;
 tx RA;
 SE - HA, dizziness, HTN, GI, infections
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Co-stimulation blocker - Immunosup; Fusion protein of LFA-3/ IgG1;
 Binds Tcell CD2 (mostly memory T) - apoptosis;
 IM admin;
 tx Psoriasis;
 SE - lymphopenia (@6-8weeks), secondary skin malignancies, SERIOUS infections, hypersensitivity and injection site rxns
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Co-stimulation blocker - Immunosup; Monoclonal Ab, anti-LFA-1 preventing binding to ICAM-1;
 Prevent binding Tcell migration thru endothelium;
 SC admin;
 tx Psoriasis;
 SE - 1st dose rxn, pain, flu-like, periph edema, UTI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CD25 inhibitor - Immunosup; Block IL-2Ra/CD25 on Tcell;
 Does not change lymphocyte #, just prevents prolif;
 Long half life - weeks;
 No neutralizing Abs develop;
 SE - severe acute hypersensitivity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CD25 inhibitor - Immunosup; Block IL-2Ra/CD25 on Tcell;
 Does not change lymphocyte #, just prevents prolif;
 Long half life - weeks;
 No neutralizing Abs develop;
 SE - severe acute hypersensitivity
 |  | 
        |  | 
        
        | Term 
 
        | Cyclosporine (Sandimmune) |  | Definition 
 
        | Calcineurin inhibitor - Immunosup; inhibit 1st phase of Tcell activation (block NFAT prod) so no IL-2, IFN-gamma;
 Subseq block of B cell act, no IL-4;
 SE - Hirsuitism, gingivial hyperplasia, renal tox, HTN, infections, secondary malignancy
 |  | 
        |  | 
        
        | Term 
 
        | Tacrolimus (FK506, Prograf) |  | Definition 
 
        | Calcineurin inhibitor - Immunosup; 100X more potent than cyclo;
 inhibit 1st phase of Tcell activation (block NFAT prod) so no IL-2, IFN-gamma;
 Subseq block of B cell act, no IL-4;
 SE - neurotox, CYP3A5 snps, renal tox, HTN, infections, secondary malignancy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcineurin inhibitor - Immunosup; inhibit 1st phase of Tcell activation (block NFAT prod) so no IL-2, IFN-gamma;
 Subseq block of B cell act, no IL-4;
 SE - renal tox, HTN, infections, secondary malignancy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Humanized monoclonal Ab - Anti-CD52; Immunosup;
 Lysis of B&T cells in bone marrow and blood (less in spleen and lymph);
 Profound, long-term lymphopenia;
 SE - infusion rxn (chills, rigor, nausea, vomit)
 |  | 
        |  | 
        
        | Term 
 
        | Methylprednisolone (Medrol) |  | Definition 
 
        | Corticosteroid - Immunosup; low dose- dec inflam cytokine,
 high dose - inc anti-inflamm proteins;
 Inhibits T&B cells;
 Short-term use;
 SE - CNS confusion, psychosis, HPA suppression, steroid withdrawal syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mTOR inhibitor - Immunosup; Prevents 2nd phase of Tcell activation (G1 arrest);
 Prevention of Bcell diff into plasma cell (dec Ig's);
 Synergistic w/ cyclo;
 SE - hyperlipid, azotemia (inc creatinine, dec GFR), TUMORS, HEPATOTOXICITY and necrosis
 |  | 
        |  | 
        
        | Term 
 
        | Mycophenolate mofetil (CellCept) |  | Definition 
 
        | Cell-cycle disrupt - Immunosup; Inhibits IMPDH - dec purines, cGMP;
 T and Bcells - selective to lymphocytes;
 Blocks memory B cell response;
 SE - GI, infections, tumors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cell-cycle disrupt - Immunosup; Blocks S phase purine formation;
 Inhibits RAC1/CD28 costimulation = apoptosis of memory Tcells;
 SE - skin cancer
 CI - pregnancy cat D; low TPMT gene product (should genotype), Allopurinol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cell-cycle disrupt - Immunosup; Blocks S phase by inhibiting Dihydrofolate reductase;
 SE - GI, severe nausea, vomit, pancytopenia, hepatotoxicity;
 CI - pregnancy cat X!!
 Pretreat w/ 5HT3-antag and corticosteroid;
 |  | 
        |  | 
        
        | Term 
 
        | Cyclophosphamide (Cytoxan) |  | Definition 
 
        | Cell-cycle disrupt - Immunosup; Prodrug to phosphoramide mustard;
 Produce lymphopenia in B cells > T (fewer B);
 SE - pancytopenia (incl anemia), acrolein metabolite (hemorrhagic cystitis, tx w/ MENSA), amenorrhea, infertility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant for analgesia/opioids; esp. for bone metastasis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant for analgesia/opioids; tx neuropathic pain (damage or infiltrate)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant for analgesia/opioids; tx neuropathic pain (damage or infiltrate)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant for analgesia/opioids; tx neuropathic pain (damage or infiltrate)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant for analgesia/opioids; tx neuropathic pain (damage or infiltrate)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant for analgesia/opioids; enhance opioid analgesia
 |  | 
        |  |